Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gidal

Showing results (121-130 of 274) with videos related to

Pageof 28
Sort By:
Journal of Pharmacy Practice|October 4, 2022
Opportunities for Community Pharmacists to Counsel Patients With Epilepsy and Seizure Clusters to Overcome Barriers and Foster Appropriate TreatmentBarry Gidal, Timothy Welty, Jon Cokley, et al.
Epilepsia|September 3, 2015
Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteersLindy L Bancke, Heather A Dworak, Keith A Rodvold, et al.
Public Health Reports (Washington, D.C. : 1974)|November 25, 2025
Birth Rates Among Teenagers With Epilepsy in Michigan: A Retrospective Analysis of a Medicaid-Insured Cohort From 2016-2022Nora Alrubaie, Barry Gidal, Eric Armour, et al.
Epilepsia|September 12, 2020
Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugsPhilip N Patsalos, Jerzy P Szaflarski, Barry Gidal, et al.
Neurology|March 27, 2016
Assessing bioequivalence of generic modified-release antiepileptic drugsEmily L Johnson, Yi-Ting Chang, Barbara Davit, et al.
Epilepsy Research|May 4, 2020
A review of the drug-drug interactions of the antiepileptic drug brivaracetamBrian D Moseley, Hugues Chanteux, Jean-Marie Nicolas, et al.
Pain Medicine (Malden, Mass.)|January 28, 2016
Impact of Data Imputation Methodology on Pain Assessment over 24 Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated with Postherpetic NeuralgiaAnne M Calkins, Jeff Gudin, Barry Gidal, et al.
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|July 8, 2024
Intranasal Delivery of Medications for the Treatment of Neurologic Conditions: A Pharmacology UpdatePatricia Osborne Shafer, Patricia Dean, Lai Brooks, et al.
Epilepsy Currents|March 15, 2021
Treatment of Super-Refractory Status Epilepticus: A ReviewJuan G Ochoa, Michelle Dougherty, Alex Papanastassiou, et al.
Therapeutic Drug Monitoring|February 1, 1995
Evaluation of a potential enantioselective interaction between ticlopidine and warfarin in chronically anticoagulated patientsB E Gidal, C A Sorkness, K A McGill, et al.
Pageof 28

Showing results (121-130 of 274) with videos related to

Sort By:
Pageof 28
Journal of Pharmacy Practice|October 4, 2022
Opportunities for Community Pharmacists to Counsel Patients With Epilepsy and Seizure Clusters to Overcome Barriers and Foster Appropriate TreatmentBarry Gidal, Timothy Welty, Jon Cokley, et al.
Epilepsia|September 3, 2015
Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteersLindy L Bancke, Heather A Dworak, Keith A Rodvold, et al.
Public Health Reports (Washington, D.C. : 1974)|November 25, 2025
Birth Rates Among Teenagers With Epilepsy in Michigan: A Retrospective Analysis of a Medicaid-Insured Cohort From 2016-2022Nora Alrubaie, Barry Gidal, Eric Armour, et al.
Epilepsia|September 12, 2020
Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugsPhilip N Patsalos, Jerzy P Szaflarski, Barry Gidal, et al.
Neurology|March 27, 2016
Assessing bioequivalence of generic modified-release antiepileptic drugsEmily L Johnson, Yi-Ting Chang, Barbara Davit, et al.
Epilepsy Research|May 4, 2020
A review of the drug-drug interactions of the antiepileptic drug brivaracetamBrian D Moseley, Hugues Chanteux, Jean-Marie Nicolas, et al.
Pain Medicine (Malden, Mass.)|January 28, 2016
Impact of Data Imputation Methodology on Pain Assessment over 24 Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated with Postherpetic NeuralgiaAnne M Calkins, Jeff Gudin, Barry Gidal, et al.
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|July 8, 2024
Intranasal Delivery of Medications for the Treatment of Neurologic Conditions: A Pharmacology UpdatePatricia Osborne Shafer, Patricia Dean, Lai Brooks, et al.
Epilepsy Currents|March 15, 2021
Treatment of Super-Refractory Status Epilepticus: A ReviewJuan G Ochoa, Michelle Dougherty, Alex Papanastassiou, et al.
Therapeutic Drug Monitoring|February 1, 1995
Evaluation of a potential enantioselective interaction between ticlopidine and warfarin in chronically anticoagulated patientsB E Gidal, C A Sorkness, K A McGill, et al.
Pageof 28